Paul Burton is the Managing Partner of 2Flo Ventures, a Chicago-based start-up studio and early-stage healthcare. See sector focus and contact routes.
Paul Burton is the Managing Partner of 2Flo Ventures, a Chicago-based start-up studio and early-stage healthcare investor he founded, having previously served as an investment banking associate at Salomon Brothers and held CEO or CFO roles at startups like Vivacelle Bio and ResQ Pharma. His firm’s investment thesis targets early-stage healthcare companies from pre-seed to Series A, with a specific focus on facilitating innovation flow to and from underserved communities to reduce healthcare outcome disparities. While specific check sizes and lead/follow behavior are not publicly detailed, 2Flo Ventures’ portfolio of nine companies has collectively raised over $100 million in capital. Notable portfolio companies include Cardio Diagnostics (where Burton serves on the board), Akan Biosciences (where he is CEO), ResQ Pharma, and Cancer IQ. Burton’s distinctive point of view centers on improving equity and fairness within the healthcare system, describing 2Flo as a venture capital firm dedicated to these goals. He holds a JD and MBA from the University of Illinois at Urbana-Champaign and serves on multiple boards, including the Sepsis Alliance and Ravinia Fest
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Evanston.
Investors like Paul Burton · Full investor directory · Investor access · Company funding database